Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Owen Scott Muir · Said 19 May 2024 · owen-1042

Quote

Not a forecast

“It doesn't escape anybody's notice that MDMA is going through the FDA-approval process with Lykos Therapeutics, and other hopeful publications are coming out. These include psilocybin analogs for PTSD, and magnesium-ibogaine for PTSD.”
· Medical Cannabis for PTSD? · substack post Paid

Closing section of a review that finds the cannabis evidence for PTSD weak and biased. The author points to a pipeline of hopeful PTSD treatments: MDMA under FDA review with Lykos, psilocybin analogs, and magnesium-ibogaine, with publications 'coming out'.

Descriptive, retrospective, or a statement of preference; no future state asserted.

← Earlier · Later → · All statements